Warning: This security is no longer trading.
defunct
Portola Pharmaceuticals, Inc. (PTLA): Price and Financial Metrics
PTLA Price/Volume Stats
| Current price | $18.03 | 52-week high | $31.73 |
| Prev. close | $17.99 | 52-week low | $5.31 |
| Day low | $17.99 | Volume | 8,094,400 |
| Day high | $18.07 | Avg. volume | 3,172,176 |
| 50-day MA | $15.97 | Dividend yield | N/A |
| 200-day MA | $18.62 | Market Cap | 1.42B |
PTLA Stock Price Chart Interactive Chart >
Portola Pharmaceuticals, Inc. (PTLA) Company Bio
Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that could significantly advance the fields of thrombosis and other hematologic diseases. The company was founded in 2003 and is based in South San Francisco, California.
PTLA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | -36.60% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | 22.34% |
Continue Researching PTLA
Here are a few links from around the web to help you further your research on Portola Pharmaceuticals Inc's stock as an investment opportunity:Portola Pharmaceuticals Inc (PTLA) Stock Price | Nasdaq
Portola Pharmaceuticals Inc (PTLA) Stock Quote, History and News - Yahoo Finance
Portola Pharmaceuticals Inc (PTLA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...